Prot #GT-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy with Sing

  • Matsangou, Maria (PD/PI)

Project: Research project

Project Details

Effective start/end date6/21/166/30/21


  • Clinical Assistance Programs, LLC (Prot #GT-201 // Prot #GT-201)
  • Galera Therapeutics, Inc (Prot #GT-201 // Prot #GT-201)